The effect of ENO1 silencing opens new possibilities for cancer treatment, based on a combination between ENO1 targeting and therapies that are able to increase oxidative and metabolic stress, such as chemotherapy and radiation, or glutaminase and oxidative phosphorylation inhibitors, respectively. The gene discussed is GLS; the disease is cancer.